Long Term Result of Intravitreal Bevacizumab in a Patient Newly Transformed to Proliferative Macular Telangiectasia Type 2

The clinical and imaging findings and therapeutic outcomes of intravitreal bevacizumab injection in a patient with macular telangiectasia type 2 are described. The patient first presented with the non-proliferative stage of the disease for 4 months, then the disease transformed to the proliferative...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozkaya, Abdullah, Alkin, Zeynep, Karakucuk, Yalcin, Yazici, Ahmet Taylan, Demirok, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841959/
https://www.ncbi.nlm.nih.gov/pubmed/24339691
http://dx.doi.org/10.4103/0974-9233.120005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841959/
https://www.ncbi.nlm.nih.gov/pubmed/24339691
http://dx.doi.org/10.4103/0974-9233.120005

Ejemplares similares